EMA: Human medicines highlights of 2021
In 2021, EMA recommended 92 medicines for marketing authorisation. Of these, 53 had a new active substance which had never been authorised…
In 2021, EMA recommended 92 medicines for marketing authorisation. Of these, 53 had a new active substance which had never been authorised…
Summary : EMA’s human medicines committe has recommended granting conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 / ritonavir) for…
Summary – The European Medicines Agency (EMA) has issued a list of about 100 regulatory science topics that need further research to close…